TD Cowen Keeps Their Buy Rating on Dianthus Therapeutics (DNTH)

In a report released on June 12, Yaron Werber from TD Cowen reiterated a Buy rating on Dianthus Therapeutics. The company’s shares closed last F...

Raccontata damarkets.businessinsider.com